FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elisabeth Quoix

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
S Couraud; G R Ferretti; P Frappé; N Girard; V Gounant; Laurent Greillier; L Guittet; A Khalil; F Laurent; P Lefebure; E Lemarié; S Liebart; B Mennecier; B Milleron; Olivier Molinier; Elisabeth Quoix; M-P Revel; P-J Souquet; B Stach; P Thomas; J Trédaniel; G Zalcman; Fabrice Barlési; B Besse; L Brouchet; O Castelnau; A B Cortot
From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF).
Jacques Cadranel; Bruno Chetaille; Christos Chouaid; Bruno Coudert; Catherine Daniel; Guillaume Danton; Florence de Fraipont; Michele Faller; Pascal Foucher; Ludovic Lacroix; Elisabeth Longchampt; Audrey Mauguen; Stefan Michiels; Franck Morin; Virginie Poulot; Elisabeth Quoix; Jerome Solassol; Thierry Urban; Virginie Westeel; Marie Wislez; Gérard Zalcman; Martine Antoine; Hélène Blons; Marie-Pierre Buisine; Jean-Pierre Pignon
Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).
Elisabeth Quoix
Therapeutic options in older patients with metastatic non-small cell lung cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elisabeth Quoix (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: S Couraud; G R Ferretti; P Frappé; N Girard; V Gounant; Laurent Greillier; L Guittet; A Khalil; F Laurent; P Lefebure; E Lemarié; S Liebart; B Mennecier; B Milleron; Olivier Molinier; Elisabeth Quoix; M-P Revel; P-J Souquet; B Stach; P Thomas; J Trédaniel; G Zalcman; Fabrice Barlési; B Besse; L Brouchet; O Castelnau; A B Cortot
From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(3):586-97.
2012: Jacques Cadranel; Bruno Chetaille; Christos Chouaid; Bruno Coudert; Catherine Daniel; Guillaume Danton; Florence de Fraipont; Michele Faller; Pascal Foucher; Ludovic Lacroix; Elisabeth Longchampt; Audrey Mauguen; Stefan Michiels; Franck Morin; Virginie Poulot; Elisabeth Quoix; Jerome Solassol; Thierry Urban; Virginie Westeel; Marie Wislez; Gérard Zalcman; Martine Antoine; Hélène Blons; Marie-Pierre Buisine; Jean-Pierre Pignon
Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(10):1490-502.
2012: Elisabeth Quoix
Therapeutic options in older patients with metastatic non-small cell lung cancer.
Therapeutic advances in medical oncology 2012;4(5):247-54.
2012: Michaël Duruisseaux; Isabelle Monnet; Jean-François Morère; Franck Morin; denis moro-sibilot; Pierre Mourlanette; Elisabeth Quoix; Jean-Charles Soria; Virginie Westeel; Marie Wislez; Laurence Baudrin; Daniel Coëtmeur; Jacques Cadranel
Chemotherapy effectiveness after first-line gefitinib treatment for advanced lepidic predominant adenocarcinoma (formerly advanced bronchioloalveolar carcinoma): exploratory analysis of the IFCT-0401 trial.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(9):1423-31.
2012: Stéphane Renaud; Nicola Santelmo; Marc Puyraveau; Elisabeth Quoix; Pierre-Emmanuel Falcoz; Jean Gustave Hentz; Sandrine Hirschi; Gilbert Massard
Gastric distension is a contributing factor to pneumonia after pulmonary resection.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2012;42(3):398-403.
2012: Florence de Fraipont; Didier Debieuvre; Marie-Christine Favrot; Pierre Hainaut; Guénaëlle Levallet; Bernard Milleron; Franck Morin; denis moro-sibilot; Mounia Mounawar; Elisabeth Quoix; Nicolas RICHARD; Isabelle Rouquette; Virginie Westeel; Gérard Zalcman; Martine Antoine; Michèle Beau-Faller; Emmanuel Bergot; Elisabeth Brambilla; Denis Braun; Christian Creveuil
An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(10):2976-86.
2012: Guillaume Mouillet; Marc Puyraveau; Elisabeth Quoix; Virginie Westeel; Gérard Zalcman; Philippe David; Alain Depierre; Alain Ducoloné; Bernard Milleron; Olivier Molinier; Elisabeth MONNET
Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(5):841-9.
2012: Guénaëlle Levallet; Jérôme Levallet; Franck Morin; denis moro-sibilot; Jean-Louis Pujol; Elisabeth Quoix; Isabelle Rouquette; Adriana O Santos; Virginie Westeel; Marie Wislez; Gérard Zalcman; Martine Antoine; Michelle Beau-Faller; Emmanuel Bergot; Elisabeth Brambilla; Jacques Camonis; Christian Creveuil; Florence de Fraipont; Didier Debieuvre; Fatéméh Dubois
High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway.
Molecular cancer therapeutics 2012;11(5):1203-13.
2012: Irina Enache; Bernard Geny; M Young Jeung; Nicolas Meyer; Georges Noel; Monique Oswald-Mammosser; Elisabeth Quoix; Catherine Schumacher; Emile Urban-Kraemer; Anne Charloux
Can exhaled NO fraction predict radiotherapy-induced lung toxicity in lung cancer patients?
Radiation oncology (London, England) 2012;7():117.
2012: Delphine Lutringer-Magnin; Elisabeth Quoix; Philippe Vanhems; Corinne Del Signore; Jacques Cadranel; G Cordier; Vincent Cottin; Nicolas Girard; Marie-Paule Lebitasy; Caroline Leroux; Jean-François Mornex
Professional exposure to goats increases the risk of pneumonic-type lung adenocarcinoma: results of the IFCT-0504-Epidemio study.
PloS one 2012;7(5):e37889.
2012: Isabelle Borget; J Cadranel; C Chouaid; B Coudert; C Daniel; E Dansin; S Friard; J Madelaine; A Madroszyk; F Morin; J-P Pignon; Elisabeth Quoix; Virginie Westeel
Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3.
The European respiratory journal 2012;39(1):172-9.
2011: L Sakhri; C Schumacher; E Bergmann; M-P Chenard; A Di Marco; D Jacqmin; Bertrand Mennecier; Elisabeth Quoix
[Atypical metastatic site of lung adenocarcinoma].
Revue de pneumologie clinique 2011;67(6):375-9.
2011: Elisabeth Quoix; Virginie Westeel; Gérard Zalcman; Bernard Milleron
Chemotherapy in elderly patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2011;74(3):364-8.
2011: Elisabeth Quoix
Optimal pharmacotherapeutic strategies for elderly patients with advanced non-small cell lung cancer.
Drugs & aging 2011;28(11):885-94.
2011: Elisabeth Quoix; Rodryg Ramlau; Alain Riviere; Erich Stoelben; Annette Tavernaro; Virginie Westeel; Anne Madroszyk; Zsolt Papai; Bruce Acres; Bérangère Bastien; Nadine Bizouarne; Jean-Yves Bonnefoy; Denis Braun; Jean-Luc Breton; Marc Buyse; Marie-Pierre Chenard; Didier Debieuvre; Piotr Koralewski; Gisèle Lacoste; Hervé Lena; Jean-Marc Limacher
Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.
The lancet oncology 2011;12(12):1125-33.
2011: Elisabeth Quoix; Pierre-Jean Souquet; J Tredaniel; fabien vaylet; Virginie Westeel; Gérard Zalcman; Laurence Baudrin; Jaafar Bennouna; Laurence Bigay-Game; Eric Dansin; Jérôme Dauba; Didier Debieuvre; Alain Ducoloné; Dominique Herman; Silvy Laporte; Armelle Lavolé; Marie-Paule Lebitasy; Bernard Milleron; Olivier Molinier; denis moro-sibilot; Jean-Philippe Oster; Eric Pichon; Michel Poudenx
Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial.
Lancet 2011;378(9796):1079-88.
2011: Nathalie Prim; Elisabeth Quoix; Michèle Beau-Faller
Tumor cell content for selection of molecular techniques for T790M EGFR mutation detection in non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(9):1615-6.
2011: Cécile Le Péchoux; D Lerouge; Elisabeth Quoix; Suresh Senan; G M Videtic; Rinus Wanders; Aaron H Wolfson; Rodrigo Arriagada; tudor ciuleanu; Ariane Dunant; Corinne Faivre-Finn; M Hatton; R Jones; R Keus; Agnès Laplanche
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(5):1154-63.
2011: L Hajouji; Bertrand Mennecier; D de la Haye Saint-Hilaire; Guillaume Bierry; Matthieu Canuet; Elisabeth Quoix
[Muscular metastasis from primary lung cancer: about seven cases].
Revue de pneumologie clinique 2011;67(2):75-81.
2011: Elisabeth Quoix; Alain Ducoloné; Bertrand Mennecier; Philippe Fraisse
[Metastatic non-small cell lung cancer: Systemic treatment of patients aged 70 and over].
Presse médicale (Paris, France : 1983) 2011;40(4 Pt 1):420-6.
2010: Nicolas Girard; Françoise Mornex; Jean-Yves Douillard; Nadine Bossard; Elisabeth Quoix; Véronique Beckendorf; Dominique Grunenwald; Elodie Amour; Bernard Milleron
Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial.
Lung cancer (Amsterdam, Netherlands) 2010;69(1):86-93.
2010: Maciej Krzakowski; Rodryg Ramlau; Jacek Jassem; Aleksandra Szczesna; Petr Zatloukal; Joachim von Pawel; Xushan Sun; Jaafar Bennouna; Armando Santoro; Bonne Biesma; François M Delgado; Yacine Salhi; Nathalie Vaissiere; Olfred Hansen; Eng Huat Tan; Elisabeth Quoix; Pilar Garrido; Jean-Yves Douillard
Phase III trial comparing vinflunine with docetaxel in second-line advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(13):2167-73.
2010: Emilie Pluquet; Jacques Cadranel; Anne Legendre; Michelle Beau Faller; Pierre Jean Souquet; Gerard Zalcman; Maurice Perol; Gislaine Fraboulet; Gerard Oliveiro; Florence de Fraipont; Elisabeth Quoix; Sylvie Lantuejoul; Bernard Milleron; denis moro-sibilot
Osteoblastic reaction in non-small cell lung carcinoma and its association to epidermal growth factor receptor tyrosine kinase inhibitors response and prolonged survival.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(4):491-6.
2010: Massimo Di Maio; Nicola Lama; Alessandro Morabito; Egbert F Smit; Vassilis Georgoulias; Koji Takeda; Elisabeth Quoix; Dora Hatzidaki; Floris M Wachters; Vittorio Gebbia; Chun-Ming Tsai; Carlos Camps; Wolfgang Schuette; Paolo Chiodini; Maria Carmela Piccirillo; Francesco Perrone; Ciro Gallo; Cesare Gridelli
Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials.
European journal of cancer (Oxford, England : 1990) 2010;46(4):735-43.
2009: Ziad Mansour; Evgenia A Kochetkova; Nicola Santelmo; Pierre Meyer; Jean-Marie Wihlm; Elisabeth Quoix; Gilbert Massard
Risk factors for early mortality and morbidity after pneumonectomy: a reappraisal.
The Annals of thoracic surgery 2009;88(6):1737-43.
2009: Elisabeth Quoix
[What is new in the epidemiology of lung cancer: non-smokers, women and the role of cannabis?].
La Revue du praticien 2009;59(7):920-4.
2009: Jacques Cadranel; Elisabeth Quoix; Laurence Baudrin; Pierre Mourlanette; denis moro-sibilot; Jean-François Morere; Pierre-Jean Souquet; Jean-Charles Soria; Franck Morin; Bernard Milleron
IFCT-0401 Trial: a phase II study of gefitinib administered as first-line treatment in advanced adenocarcinoma with bronchioloalveolar carcinoma subtype.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(9):1126-35.
2009: Elisabeth Quoix
Prognostic factors for survival in extensive stage small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(8):1041; author reply 1041.
2009: Cécile Le Péchoux; Ariane Dunant; Suresh Senan; Aaron H Wolfson; Elisabeth Quoix; Corinne Faivre-Finn; tudor ciuleanu; Rodrigo Arriagada; Richard Jones; Rinus Wanders; Delphine Lerouge; Agnès Laplanche
Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
The lancet oncology 2009;10(5):467-74.
2009: Michèle Beau-Faller; M Legrain; A-C Voegeli; Eric Guérin; T Lavaux; A-M Ruppert; Agnès Neuville; Gilbert Massard; Jean-Marie Wihlm; Elisabeth Quoix; Pierre Oudet; Marie-Pierre Gaub
Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping.
British journal of cancer 2009;100(6):985-92.
2009: A-M Ruppert; Michèle Beau-Faller; Agnès Neuville; Eric Guerin; A-C Voegeli; Bertrand Mennecier; M Legrain; A Molard; Mi-Young Jeung; Marie-Pierre Gaub; Pierre Oudet; Elisabeth Quoix
EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up.
The European respiratory journal 2009;33(2):436-40.
2009: Delphine N Antoni; Mi-Young Jeung; Bertrand Mennecier; Anne-Marie Ruppert; Gilbert Massard; Elisabeth Quoix
A two-faced young woman.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(2):240-1.
2009: Stéphane Oudard; Elisabeth Quoix; Arash Jenabian; Loïc Bergougnoux; Kader Chouahnia; Jean-Marc Ferrero; Jean-Louis Misset; Dominique Spaëth
[Efficacy of weekly epoetin Beta in the treatment of chemotherapy-induced anemia in solid tumors].
Thérapie 2009;64(1):17-25.
2008: Elisabeth Quoix
[Stage IV NSCLC. Second-line therapy for metastatic non-small cell lung cancer].
Revue des maladies respiratoires 2008;25(8 Pt 2):3S113-8.
2008: Petr Zatloukal; Radj Gervais; Johan Vansteenkiste; Léon Bosquee; Christiana Sessa; Etienne Brain; Eric Dansin; Thierry Urban; Nadine Dohollou; Michèle Besenval; Elisabeth Quoix
Randomized multicenter phase II study of larotaxel (XRP9881) in combination with cisplatin or gemcitabine as first-line chemotherapy in nonirradiable stage IIIB or stage IV non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(8):894-901.
2008: Rodryg Ramlau; Elisabeth Quoix; Janusz Rolski; Miklos Pless; Herve Lena; Eric Lévy; Maciej Krzakowski; Dagmar Hess; Eric Tartour; Marie-Pierre Chenard; Jean-Marc Limacher; Nadine Bizouarne; Bruce Acres; Céline Halluard; Thierry Velu
A phase II study of Tg4010 (Mva-Muc1-Il2) in association with chemotherapy in patients with stage III/IV Non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(7):735-44.
2008: Ziad Mansour; Evgenia A Kochetkova; Nicola Santelmo; Xavier Ducrocq; Elisabeth Quoix; Jean-Marie Wihlm; Gilbert Massard
Persistent N2 disease after induction therapy does not jeopardize early and medium term outcomes of pneumonectomy.
The Annals of thoracic surgery 2008;86(1):228-33.
2008: Michèle Beau-Faller; Anne-Marie Ruppert; Anne-Claire Voegeli; Agnès Neuville; Nicolas Meyer; Eric Guerin; Michèle Legrain; Bertrand Mennecier; Jean-Marie Wihlm; Gilbert Massard; Elisabeth Quoix; Pierre Oudet; Marie P Gaub
MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(4):331-9.
2008: Elisabeth Quoix
Topotecan in the treatment of relapsed small cell lung cancer.
OncoTargets and therapy 2008;1():79-86.
2007: Bernard Milleron; Elisabeth Quoix
[Treatment of non-small cell bronchopulmonary cancer in the elderly].
Revue des maladies respiratoires 2007;24(6):796-8.
2007: G Albrand; E Biron; Isabelle Boucot; LJ Couderc; Bruno Crestani; MC Dombret; HERVE GUENARD; M Grivaux; M P Hervy; B Housset; J Jougon; E Orvoen Frija; François Piette; T Pignon; G Pinganaud; F Puisieux; Elisabeth Quoix; E Sauty; fabien vaylet; B Wary; Sébastien Weill-Engerer; V Westeel; Marie Wislez
[Lung cancer in the elderly subject].
Revue des maladies respiratoires 2007;24(6):703-23.
2006: Elisabeth Quoix
[Lung cancer and oncogeriatrics - Current status].
Revue de pneumologie clinique 2006;62(6 Pt 2):2S5-7.
2006: Mark G Kris; Giuseppe Giaccone; Angela Davies; Masahiro Fukuoka; David H Garfield; Jacek Jassem; Elisabeth Quoix; Alan B Sandler; Giorgio V Scagliotti; Jan P van Meerbeeck; Howard West
Systemic therapy of bronchioloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(9 Suppl):S32-6.
2006: Elisabeth Quoix
[What is to be expected from population studies in relation to clinical trials?].
Revue de pneumologie clinique 2006;62 Spec no 1():1S19-21.
2005: A Le Louam; F Jung; A Kruchen; Elisabeth Quoix
[An inter-university diploma on tobacco and smoking cessation: pedagogical evaluation and professional impact].
Santé publique (Vandoeuvre-lès-Nancy, France) 2005;17(2):241-53.
2004: Elisabeth Quoix
[Particularities of lung cancer in women].
Revue de pneumologie clinique 2004;60(5 Pt 3):4S27-4S30.
2003: A Depierre; Elisabeth Quoix; B Milleron
[Treatment of localised forms of non small cell bronchial cancers: perspectives in 20003].
Revue des maladies respiratoires 2003;20(2 Pt 1):173-6.
2002: J Cosaert; Elisabeth Quoix
Platinum drugs in the treatment of non-small-cell lung cancer.
British journal of cancer 2002;87(8):825-33.
2001: Elisabeth Quoix
[Age is not a formal or relative risk factor for lung cancer surgery].
Revue des maladies respiratoires 2001;18(2):105-6.
2001: Elisabeth Quoix
[IFCT --French Intergroup of Thoracic Cancerology: presentation, protocols].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2001;5(1):80-1.
2000: Elisabeth Quoix
[Bronchial epidermoid cancers and adenocarcinomas. Epidemiology, pathology, etiology, diagnosis, evolution, treatment].
La Revue du praticien 2000;50(20):2295-301.
2000: Fabrice Andre; Dominique Grunenwald; Jean-Pierre Pignon; Antoine Dujon; Jean-Louis Pujol; Pierre-Yves Brichon; Laurent Brouchet; Elisabeth Quoix; Virginie Westeel; Thierry Le Chevalier
Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(16):2981-9.
2000: E Lemarié; Elisabeth Quoix; B Milleron
[Medical ethics and therapeutic progress: the example of lung cancers. Help, Hippocrates!].
Revue des maladies respiratoires 2000;17(3):707-8.
1998: Giuseppe Giaccone; C Manegold; R Rosell; U Gatzemeier; Elisabeth Quoix
An update on European randomized studies in non-small cell lung cancer.
Seminars in oncology 1998;25(4 Suppl 9):11-7.
1998: N Schmitz; Elisabeth Quoix; B Gasser; G Pauli
[Bronchopulmonary carcinosarcoma].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1998;19(7):506-8.
1998: Jean-Paul Sculier; Elisabeth Quoix
[Non-small-cell bronchial cancers at stage III. Therapeutic strategy].
Revue des maladies respiratoires 1998;15(3 Pt 2):319-22.
1997: D Johnson; Rodrigo Arriagada; N Barthelemy; James A. Bonner; P Bonomi; B Enami; E Minatel; K Park; Elisabeth Quoix; P Van Houtte
Post-operative adjuvant therapy for non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1997;17 Suppl 1():S23-5.
1997: A Charloux; M Rossignol; A Purohit; David Small; Norman Wolkove; G Pauli; Elisabeth Quoix; Harvey Kreisman
International differences in epidemiology of lung adenocarcinoma.
Lung cancer (Amsterdam, Netherlands) 1997;16(2-3):133-43.
1997: A Charloux; Elisabeth Quoix; Norman Wolkove; David Small; G Pauli; Harvey Kreisman
The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma.
International journal of epidemiology 1997;26(1):14-23.
1995: B Wieskopf; C Demangeat; Ashok Purohit; R Stenger; P Gries; Harvey Kreisman; Elisabeth Quoix
Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role.
Chest 1995;108(1):163-9.
1995: Pieter E Postmus; Egbert F Smit; H Haaxma-Reiche; nico van zandwijk; Andrea Ardizzoni; Elisabeth Quoix; A Kirkpatrick; TM Sahmoud; G Giaccone
Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):660-5.
1995: Emmanuel Andrès; F Courouau; Jean-Emmanuel Kurtz; Jean-Marc Limacher; Elisabeth Quoix
[Curative antifungal treatment of invasive pulmonary aspergillosis].
Revue de pneumologie clinique 1995;51(4):228-31.
1994: Elisabeth Quoix
[Primary bronchopulmonary cancers. Epidemiology, pathological anatomy, etiology, diagnosis, course, treatment].
La Revue du praticien 1994;44(16):2237-43.
1994: Alain Depierre; B Milleron; B Lebeau; denis moro-sibilot; C Chastang; Pascale Jacoulet; N Paillot; Elisabeth Quoix; H Janicot; J N Lombard
An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer.
Seminars in oncology 1994;21(3 Suppl 4):16-9.
1994: C Cotto; Elisabeth Quoix; F Thomas; S Henane; Véronique Trillet-Lenoir
Phase I study of the somatostatin analogue somatuline in refractory small-cell lung carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(3):290-1.
1994: Thierry Le Chevalier; Rodrigo Arriagada; Elisabeth Quoix; P Ruffie; M Martin; Jean-Yves Douillard; M Tarayre; M J Lacombe-Terrier; Agnès Laplanche
Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma.
Lung cancer (Amsterdam, Netherlands) 1994;10 Suppl 1():S239-44.
1994: J Cox; D Ball; Chandra P Belani; N Choi; R Gralla; J Halle; R Komaki; T Le Chevalier; T Ohnoshi; Elisabeth Quoix
Dose intensity in lung cancer treatment.
Lung cancer (Amsterdam, Netherlands) 1994;10 Suppl 1():S11-3.
1994: Alain Depierre; C Chastang; Elisabeth Quoix; B Lebeau; F Blanchon; N Paillot; E Lemarie; B Milleron; denis moro-sibilot; J Clavier
Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(1):37-42.
1994: denis moro-sibilot; Pascale Jacoulet; Elisabeth Quoix; E Ranfaing; E Brambilla; F Capron; jean leon lagrange; B Milleron; B Lebeau; P Ruffie
Small cell lung cancer: patients surviving longer than thirty months. Groupe d'oncologie de langue française.
Anticancer research 1994;14(1B):301-4.
1994: Elisabeth Quoix
[Significance of serum tumor markers in the diagnosis and management of bronchopulmonary cancers].
Revue des maladies respiratoires 1994;11(4):319-20.
1993: Pierre-Jean Souquet; F Chauvin; J P Boissel; R Cellerino; Y Cormier; Patricia Anne Ganz; S Kaasa; J L Pater; Elisabeth Quoix; E Rapp
Polychemotherapy in advanced non small cell lung cancer: a meta-analysis.
Lancet 1993;342(8862):19-21.
1992: I Monnet; Patrick Chariot; Elisabeth Quoix; Pierre Ruffié; S Voisin; T Le Chevalier; J C Saltiel; H de Cremoux
Extensive small-cell lung cancer. A randomized comparison of two chemotherapy programs with early crossover in instances of failure. Association pour le Traitement des Tumeurs Intra-Thoraciques (ATTIT).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(10):813-7.
1992: A Depierre; C Chastang; B Lebeau; J Clavier; B Milleron; C Brambilla; Elisabeth Quoix; E Lemarié
[A must: evaluation of adjuvant chemotherapy in bronchogenic cancers by a randomized trial].
Revue de pneumologie clinique 1992;48(2):45-7.
1992: Pieter E Postmus; Ted A W Splinter; F M Palmen; D N Carney; J Festen; J T Burghouts; C Vendrik; K Roozendaal; A S Planting; Elisabeth Quoix
Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell lung cancer in a randomised phase II study. The EORTC Lung Cancer Cooperative group.
European journal of cancer (Oxford, England : 1990) 1992;28(1):96-100.
1992: Thierry Le Chevalier; Rodrigo Arriagada; M Tarayre; M J Lacombe-Terrier; Agnès Laplanche; Elisabeth Quoix; P Ruffie; M Martin; Jean-Yves Douillard
Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma.
Journal of the National Cancer Institute 1992;84(1):58.
1991: Rodrigo Arriagada; Thierry Le Chevalier; Elisabeth Quoix; P Ruffie; H de Cremoux; Jean-Yves Douillard; M Tarayre; Jean-Pierre Pignon; Agnès Laplanche
ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Féderation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists.
International journal of radiation oncology, biology, physics 1991;20(6):1183-90.
1991: Thierry Le Chevalier; Rodrigo Arriagada; Elisabeth Quoix; P Ruffie; M Martin; M Tarayre; M J Lacombe-Terrier; Jean-Yves Douillard; Agnès Laplanche
Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients.
Journal of the National Cancer Institute 1991;83(6):417-23.
1990: F Jehl; J Debs; C Herlin; Elisabeth Quoix; C Gallion; H Monteil
Determination of navelbine and desacetylnavelbine in biological fluids by high-performance liquid chromatography.
Journal of chromatography 1990;525(1):225-33.
1989: Thierry Le Chevalier; C Zabbe; S Gouva; M L Cerrina; Elisabeth Quoix; A Riviere; P Berthaud; C Prache; J Berille
Phase II multicentre study of the nitrosourea fotemustine in inoperable squamous cell lung carcinoma.
European journal of cancer & clinical oncology 1989;25(11):1651-2.
1989: Gabrielle Pauli; Jean-Claude Bessot; Elisabeth Quoix
[Effect of the environment on the development of respiratory allergies].
Revue de pneumologie clinique 1989;45(6):231-6.
1986: Elisabeth Quoix; H Finkelstein; Norman Wolkove; H Kreisman
Treatment of small-cell lung cancer on protocol: potential bias of results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(9):1314-20.
1982: A Vandevenne; Elisabeth Quoix; G Burghard
[Mac Leod syndrome].
La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris 1982;58(7):397-402.